Tamoxifen and Quercetin Interact with Type II Estrogen Binding Sites and Inhibit the Growth of Human Melanoma Cells
- 1 August 1995
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 105 (2) , 248-253
- https://doi.org/10.1111/1523-1747.ep12317599
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Protein kinase C inhibitors induce apoptosis in human malignant glioma cell linesFEBS Letters, 1994
- The biological evaluation of novel antioestrogens for the treatment of breast cancerCritical Reviews in Oncology/Hematology, 1993
- Synergistic antiproliferative activity of tamoxifen and cisplatin on primary ovarian tumoursEuropean Journal Of Cancer, 1992
- Production and Characterization of the Murine Monoclonal Antibody 2G10 to a Human T4-Tyrosinase EpitopeJournal of Investigative Dermatology, 1991
- Enhancement of the antiproliferative activity of cis‐diamminedichloroplatinum(II) by quercetinInternational Journal of Cancer, 1990
- Bioflavonoid interaction with rat uterine type ii binding sites and cell growth inhibitionJournal of Steroid Biochemistry, 1988
- Reversion of the transformed phenotype of B16 mouse melanoma: Involvement of an 83 kd cell surface glycoprotein in specific growth inhibitionCell, 1986
- The effect of tamoxifen on the growth of human malignant melanoma in VitroEuropean Journal of Cancer and Clinical Oncology, 1984
- Primary Bioassay of Human Tumor Stem CellsScience, 1977
- THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONSAnnals of the New York Academy of Sciences, 1949